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Background: Cutaneous leishmaniasis is a tropical disease affecting over one million patients annually and
Leishmania (L.) mexicana is one of the major etiological agents in the Americas. Here we established the first
experimental infection of L. (L.) mexicana in canids.
Methods: Beagle dogs were infected intradermally with culture-derived L. (L.) mexicana. We followed skin ulcer
development, histopathological signs, parasite burden and the immune status of the infected dogs.
Results: All infected dogs developed uniform oval-craterform ulcers similar to those observed in humans, associated
with mixed T helper 1/T helper 2 immune responses. Parasites were detected in the healed lesions 15 weeks
post-infection. Higher anti-Leishmania IgG levels correlated with larger lesions and high IgG1/IgG2 ratio was associated
with some level of splenomegaly.
Conclusions: The canine model described in this work will be of use for further understanding of L. (L.) mexicana
immunopathogenensis, and for drug and vaccine development.
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The leishmaniases are a group of parasitic disease affec-
ting up to 1.4 millions people annually [1]. Cutaneous
(Chiclero’s Ulcer), mucocutaneous and visceral leish-
maniasis (Kala-azar) are the different clinical forms of the
disease, which is caused by parasites from two subgenus:
Leishmania (Leishmania) and Leishmania (Viannia). The
parasite is transmitted by sand flies of the Phlebotomus
and Lutzomyia genus in the old and new world, res-
pectively. Cutaneous leishmaniasis (CL) ranks ninth of
infectious neglected-tropical diseases, with an estimated
burden of 1.2 million new cases per year, and of 770,000
DALYs (disability-adjusted life years) [1-3]. L. (L.)
mexicana is one of the major species responsible for CL
in the Americas. It can be found in Argentina, Brazil,
Costa Rica, Guatemala, and as far north as Mexico [1,4,5].* Correspondence: vladimir.cruz@uady.mx
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article, unless otherwise stated.In Mexico, the Ministry of Health reports an incidence of
500-900 cases annually, although the disease is likely to be
under-reported [5,6]. Drug treatment for infected patients
is complicated, with only few drugs available with limited
efficacy, and a vaccine is still in early experimental stages
[1,5,7,8].
Dogs are believed to play an important role as a do-
mestic reservoir of Leishmania parasites, as demonstra-
ted for L. (L.) chagasi [9]. This is due to relatively high
natural infection rates in many regions, ranging from 4
to 60% [10-15] and the life-long persistence of parasites,
particularly in the skin, with or without clinical signs of
disease [9]. Drug treatment of infected dogs is not rec-
ommended, to prevent the emergence of drug resistance
of the parasite [16]. As a consequence, some countries
such as Brazil are recommending the culling of infected
dogs to prevent spreading of the disease, although the
efficacy of such measure has been criticized [17]. An im-
portant priority is thus to develop veterinary vaccines,
which require appropriate animal models for their evalu-
ation. Rodent models have been extensively used for thetral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
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outbred mouse strains and hamsters [18,19], and have
provided key information on the immunopathology of
the disease. However, studies in dogs are also warranted
for a further understanding of their role in Leishmania
transmission and for testing drug and vaccine efficacy
[20,21].
Most studies on canine leishmaniasis have focused on
the visceral form caused by L. (L.) chagasi or L. (L.)
infantum, and are based on observations of both natur-
ally and experimentally infected animals [21-27]. Unex-
pectedly, canine cutaneous leishmaniasis has been little
studied in domestic dogs and is poorly described. A high
prevalence of infection by L. (V.) braziliensis, L. (V.)
guayanensis, and L. (L.) panamensis has been reported
in dogs from Colombia [27,28]. In Mexico, cases of ca-
nine leishmaniasis have been reported, possibly caused
by L. (L.) infantum [29], although the parasite species
was not determined. Cases of natural infection with L.
(L.) mexicana have also been described [30]. Dogs natur-
ally infected with L. (V.) braziliensis were found to
present thrombocytopenia, anemia and skin lesions [31].
Parasites could be observed in 35% of the lesions, which
also presented diffuse chronic inflammation of the der-
mis and fibrinoid degeneration, and less frequently
some vasculitis [32]. However, experimental models of
canine cutaneous leishmaniasis are scarce. The experi-
mental infection with L. (V.) brasiliensis was found to
induce a cutaneous lesion in three of four mongrel dogs,
4-8 months after infection, and the lesions tended to
heal after 3-5 months [33]. Histologically, these lesions
had similar characteristics as those observed in naturally
infected animals [33], but additional studies are needed
to further characterize this dog model.
In this study, we developed a canine model of cutane-
ous leishmaniasis caused by experimental infection with
L. (L.) mexicana parasites, the main species circulating
in Southern Mexico and Central America. We described
the clinical, parasitological and immunological aspects of
the experimental infection in Beagle dogs, which provide
a good model for the future testing of novel drugs or
vaccines against cutaneous leishmaniasis, as well as for




Six Beagle dogs from three litters and aged between two
and three months were used. Animals were acclimated
for three/four months in the animal facility. Tempera-
ture, light and food were controlled. They received treat-
ment against helminths and were vaccinated against
Rabies virus, Canine distemper virus, Type 2 Adenovirus,
Coronavirus, Parainfluenza, Parvovirus and Leptospira.All animal procedures were performed according to
national and international guidelines approved by the
Institutional Bioethics Committee from the Autono-
mous University of Yucatan (authorization number
CBI-CIR-11-04).
Parasites and infection
Leishmania (L.) mexicana MHET/MX/97/Hd18 strain
was cultured in 199 media with 15% of fetal bovine se-
rum, 5 μM mercaptoethanol, 20 mM sodium pyruvate,
100 IU penicillin and 100 mg/mL streptomycin, and 5%
of filtered human urine. Under general anesthesia (keta-
mine/xilazine, 8:1 mg/kg, iv), Beagle dogs received 7 ×
107 promastigotes resuspended in 50 μl of PBS solution
intradermally on the shaved back [34].
Clinical studies
Beagle dogs were under daily examination for clinical
signs including rectal temperature, breath and heart rate.
Additionally, feces color, presence of polydipsia, polyuria
and/or any abnormal excretions were observed. Skin le-
sions were photographed and measured weekly using a
Vernier Caliper over a period of 15 weeks.
Parasite burden
SYBR Green-based real time-PCR was optimized to
quantify L. (L.) mexicana parasite burden in prescapular
lymph nodes and skin lesions. First, 25 mg of tissue was
ground with a morter and pestle and DNA was obtained
with a Wizard® Genomic DNA purification Kit (Promega
Madison WI) following the manufacturer’s instructions.
We used primers targeting a 140 bp sequence from L.
(L.) mexicana minicircle: forward primer: 5′-AATGC
GAGTGTTGCCCTTTTG-3′ and reverse primer: 5′-
GCCGAACAACGCCATATTAACC-3′ [35]. Reactions
contained 50 ng of DNA in a reaction volume of 20 μl
with 500 nM (each) forward and reverse primers, and
1× Kappa SYBR FAST universal qPCR mix. Reactions
consisted of a 10 min activation at 95°C followed by
40 cycles of 15 s at 95°C and 1 min 60°C, and a high
resolution melt curve analysis at the end of the reaction.
A standard curve was prepared with uninfected dog
DNA spiked with serial dilutions of L. (L.) mexicana
DNA covering a dynamic range of 150 to 1.5 × 106 para-
site equivalent/reaction. All samples and standards were
run in triplicates and the standard deviation among trip-
licates was less than 0.6 Cq.
Pathology
Dogs were euthanized 15 weeks post-infection with a
barbiturate overdose and necropsies were performed im-
mediately registering detail of cavities, organs and fluids.
Spleen and Liver were extracted, weighted and measured
[36]. Biopsies from the skin, spleen, prescapular lymph
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sections were stained with hematoxylin and eosin to
evaluate lesions and/or parasites.
Serology
The humoral immune response induced by L. (L.) mexicana
infection was evaluated by measuring levels of total IgG,
IgG1 and IgG2 subtypes, against parasite lysate and NH36
recombinant antigen [37,38]. Soluble L. (L.) mexicana
Antigen (SLA) was prepared from parasites cultured as
described previously following 6 days culture in 199
Hanks® medium (Life technologies Carlsbad CA). Briefly,
4 × 105/mL parasites were washed three times with
phosphate buffer solution (PBS) pH 7.2 and sonicated by
three ultrasound cycles (Sonics Vibra Cell 130, Newtown
CA) of 1 min at 45 W at 4°C. The lysed suspension was
centrifuged at 5000 × g for 30 min at 4°C. The supernatant
was recollected and stored in aliquots at 70°C until used
[39]. Recombinant NH36 (rNH36) was generously
provided by Dr. Peter Hotez (Baylor College of Medicine,
Houston, TX, USA). Ninety six-well plates were coated
overnight with soluble L. (L.) mexicana MHET/MX/97/
Hd18 antigen (20 μg/ml) or rNH36 recombinant protein
(2.5 μg/ml). After blocking, plasma samples (1:100 and
1:50 dilutions for total IgG and IgG isotypes, respectively)
were incubated for 1 h at 37°C, and then washed.
Phosphatase-conjugated rabbit anti-dog IgG (1:4000
dilution, Sigma, USA), peroxidase-conjugated goat anti-
dog IgG1 or sheep anti-dog IgG2 (1:1000 dilution, Serotec,
UK) were added and after washing, the plates were
revealed with pNPP or o-phenylenediamine substrates,
respectively, and absorbance was measured on a Bio-Rad
550 microplate reader.
Cytokine levels
Cytokines IFNγ and IL-10 levels were quantified in
plasma as well as spleen and liver extract supernatants.
For this, 1 g of fresh tissue was ground with a mortar
and pestle and resuspended with 2 mL of RPMI-1640
medium (Sigma-Aldrich Inc, St. Louis, MO). The ho-
mogenates were centrifuged at 10,000 g for 15 minutes
at 4°C and the supernatants were stored at -70°C [40].
IFNγ and IL-10 DuoSet Canine kits (R&D Systems Inc.,
Minneapolis) were used to measure cytokine levels in
tissue supernantants and plasma samples according to
the instructions of the manufacturer.
Results
Clinical evaluation
Dogs were infected with a dose of 7 × 107 L. (L.) mexicana
promastigotes via intradermal route. All animals showed a
local erythema nine days post-infection at the site of
injection. At 3-4 weeks post-infection, we observed a
papule in all animals, which ulcerated and expanded, toform a typical oval crater-like lesion (Figure 1). The majo-
rity of animals presented a lesion of about 1 cm in dia-
meter, with some variation (range of 0.4 - 1.8 cm in
diameter). Active skin ulcers were present for a median of
8 weeks until healing, with large individual variations of
this duration, ranging from six to 11 weeks (Figure 1). The
lesion in one male dog never healed, as it was still active
after 15 weeks of infection. Some effect of the litter of ori-
gin was observed in size and duration of the lesions. Bea-
gles 1 and 6 belonging to one litter had larger lesions,
while Beagles 2 and 3 from another litter presented
smaller but long-lasting lesions and Beagles 4 and 5
from a third litter had intermediate size lesions. Daily
rectal temperature measurements showed weekly in-
creases >38.6°C in all dogs. Pyrexia was also observed
in two dogs on day 25 post-infection, just after ulcer
formation, reaching 39.3 and 40°C, respectively.
Pathology and histopathology
Infected animals were euthanized at week 15 post-
infection, when lesions had healed except in one dog,
and necropsy was carried out to detect any gross abnor-
mality. All analyzed tissues appeared macroscopically nor-
mal. Spleen was weighted and the data normalized to
body weight. Four of the six dogs (three males and one fe-
male) presented a splenomegaly outside the normal range
(Figure 2).
Biopsies from different tissues were also analyzed for
histopathologic damage. Skin tissue from the healed le-
sions showed focal inflammatory cell infiltration in the
dermis around adipose tissue, and a loss of epidermis in-
tegrity (Figure 3C). Prescapular lymph nodes presented
disseminated atrophy with interstitial edema and an en-
larged cortical layer with necrotic fibrinoid zones. There
was also an intense vasculitis in this tissue (Figure 3A).
The liver of Beagle 4 and 6 showed hydropic and lipid
severe degeneration around the central area and multiple
focus of oncotic necrosis (Figure 3B). In the kidneys, a se-
vere case of inflammation and interstitial nephritis was
found in Beagle 4. There was an extensive histiocytic and
lymphocytic infiltrate displacing renal tubules (Figure 3D).
Some inflammation was observed in the kidneys of the
other infected animals. However, no parasites or infected
cells were observed in any of the tissue sections.
Parasite burden
Parasite burden was measured at the site of the healed
lesion and in the prescapular lymph node by qPCR tar-
geting L. (L.) mexicana kDNA. Parasites were detected
in all biopsies from all infected animals, with similar
parasite burdens in the skin and in the lymph nodes
(Figure 4). Parasite burden varied from 36-3750 parasites
equivalent/mg in the lymph nodes and between 57-301
parasites equivalent/mg in the healed lesions. A higher
Figure 2 Splenomegaly ratio of L. (L.) mexicana infected Beagle
dogs. Animals were euthanized at 13-16 months old, 16 weeks after
infection. The grey area with the horizontal line represents the mean
and standard deviation distribution of normal Beagle dogs of the
same age YANG, 1989.
Figure 1 Time course of skin lesion development in dogs infected with L. (L.) mexicana. Beagle dogs were infected with 7 × 107 parasites
intradermally and lesion size was measured weekly with a caliper (A). Black filled symbols are male dogs and empty symbols are for females.
Insert shows the median and range of the lesion size. (B) representative images of lesions at 2, 6, 10 and 14 weeks post-infection. Scale is in cm.
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ated with increased splenomegaly, although this did not
reach statistical significance (R2 = 0.62, P = 0.06), and no
association was found with the parasite burden in the
lymph nodes.
Immune response
The immune response of the infected dogs was analyzed
to determine whether potential immune responses cor-
related with disease progression. We measured serum
antibody levels as well as IFNγ and IL-10 cytokine le-
vels in serum and tissues at different time points. Anti-
Leishmania total IgG rapidly increased following infection
to reach a maximum level at 8 weeks post-infection. Anti-
body levels were maintained up to 12 weeks post-infection
(Figure 5A). High IgG levels were significantly associated
with a large lesion size (R2 = 0.87, P = 0.005).
Analysis of antibody isotypes showed a gradual IgG iso-
type switching over the course of infection, from a pre-
dominant IgG2 isotype at four weeks post-infection to a
predominant IgG1 isotype at 12 weeks post-infection, as
indicated by the changes in IgG1/IgG2 ratio (Figure 5B).
A high IgG1/IgG2 ratio at 12 weeks post-infection was
Figure 3 Photomicrographs of hematoxylin eosin stained sections of tissues from infected dogs. (A) Cortical zone of the prescapular
lymph node. GC: Germinal Centre. Magnification 10×. (B) Liver section, magnified 20×. Hepatocytes present hydropic degeneration (arrowhead).
Necrotic cells are scattered throughout parenchyma (arrows). CV: Central vein. (C) Epidermis section magnified 20×. Inflammatory infiltrate is
present in the dermis (arrows) and epidermis integrity is lost by orthokeratotic hyperkeratosis (arrowheads). (D) Kidney section magnified 10×.
Severe inflammatory infiltrate is observed in the interstitium (arrowheads). Severe lymphocytic and histiocytic inflammatory infiltrate is around
necrotic zone (arrow).
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0.04), and tended to be associated with an increased para-
site burden in the lesion (R2 = 0.42, P = 0.15). We also
evaluated NH36-specific antibodies. Anti-NH36 IgG levels
reached their maximum at 8 weeks post-infection, but
then presented some decrease at 12 weeks post infec-
tion (Figure 5C).Figure 4 Quantification of parasite burden by qPCR. (A) High resolutio
positive amplification products (gray lines) compared to uninfected negativ
skin healed lesions at 15 weeks post-infection.IFNγ and IL-10 cytokines were measured in liver and
spleen tissue homogenates, as well as in serum samples
at 15 weeks post-infection, by ELISA. IL-10 could not be
detected in spleen or plasma samples, and it was only
detected in liver samples (Figure 6). On the other hand,
IFNγ was found in all samples and appeared to be the
predominant cytokine compared to IL-10 (Figure 6). Non melting curve of qPCR products showing the specificity of the
e controls (red curves). (B) Parasite burden in the lymph nodes and
Figure 5 Antigen-specific humoral immune response in Beagle
dogs following infection with L. (L.) mexicana. (A) Anti-L. mexicana
total IgG levels were measured by ELISA and read at 415 nm. (B) IgG1/
IgG2 ratio was similarly measured at 490 nm. (C) rNH36-specific IgG
levels were determines as anti-Leishmania total IgGs.
Figure 6 IFNγ and IL-10 cytokines levels in infected Beagle
dogs. Cytokine concentrations were determined by ELISA in the
supernatant of liver and spleen extracts, and in plasma samples.
Data are presented as mean and standard deviation.
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vels and the other immune or parasitological parameters
(P > 0.05), although higher IFNγ levels in the spleen
and in the liver tended to be associated with lower
anti-Leishmania IgG, as well as a shorter duration and
smaller size of the skin lesions.
Discussion
While visceral leishmaniasis has been extensively studied
in dogs and several experimental models have been de-
scribed [20,26,34,41-43], very little is known about ca-
nine cutaneous leishmaniasis. We present here a first
detailed model of experimental infection with L. (L.)
mexicana in Beagle dogs.
Infection of dogs with L. (L.) mexicana parasites led to
the development of a typical ulcerated skin lesion in all
six infected animals, with a rather rapid onset after 3-4
weeks of infection. Thus, in spite of some variability in
terms of lesion size and duration, this infection model
appeared very reproducible. A previous attempt of in-
fection of mongrel dogs with 3 × 107 L. (V.) braziliensis
promastigotes resulted in cutaneous lesion development
in only three of four animals, and after a longer and vari-
able incubation period of 8-32 weeks [33]. Lesion dur-
ation in the L. (V.) braziliensis model was also highly
variable, ranging from 16 to 32 weeks [33]. This elevated
variability and time length made this former model of
limited practical use. A higher parasite dose (1 × 109)
has also been used in a model of canine visceral leshma-
niasis, but it led to limited clinical signs [44].
The clinical and pathological evolution of L. (L.) mexi-
cana we described in this study was also very similar to
what has been described for naturally-occurring cutane-
ous leishmaniasis in dogs. Thus, dogs naturally infected
with L. (V.) braziliensis or L. panamensis present skin le-
sion varying in size from 0.4-10 cm [27,29]. Similarly,
the histopathologic damage that we observed in the skin
and other tissues is very similar to that observed in nat-
urally infected animals [32,45]. Remarkably, our obser-
vation of lymphoid infiltration in the kidney is a first
report indicating possible renal damage in experimental
cutaneous leishmaniasis. The induction of glomerulo-
nephritis during infection with L. (L.) infantum has been
recently attributed to the deposition of immune complex
following a limited cellular immunity [46]. In addition, it
is important to note that L. (L.) mexicana can cause a
rather wide spectrum of clinical disease, including dif-
fuse and visceral forms in some cases, particularly in pa-
tients with low immune status [47-49].
Also similar to the natural infection is the apparent
absence of parasites in the healed lesion as assessed mi-
croscopically in tissue sections [32]. However, using a
technique with higher sensitivity such as qPCR, we
clearly demonstrated an important parasite burden up
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the secondary lymphoid organs of all six infected ani-
mals. While this assay relies on the detection of para-
site DNA, the presence of live parasites is highly likely, as
observed in many animal models of Leishmania infection.
These important results suggest that infected dogs have
reached an asymptomatic stage, but parasite persistence
indicated that, on one hand infection may be reactivated
upon alteration of their immune status, and on the other
hand, they remain a potential source of infection and may
serve as a reservoir of the parasite. In Brazil, it has been
clearly established that domestic dogs are the main reser-
voir of L. chagasi [20,21,50], but the role of dogs in the
transmission of Leishmania species causing cutaneous
forms of the disease is not well understood [51]. Observa-
tions of long lasting ulcer lesions and a high susceptibility
to infection in dogs from Argentina suggested that they
could play an important epidemiological role in the trans-
mission of Leishmania parasites species causing cutaneous
leishmaniasis [51]. This has important implications for the
definition of epidemiological control measures. Indeed,
the massive euthanasia of dogs in Brazil has had a ques-
tionable efficacy to reduce infection rate in humans [17],
and as a consequence, the World Health Organization has
now prioritized the development of veterinary vaccines
[34,41]. Therefore, our model of canine cutaneous leish-
maniasis may be very helpful for the evaluation of vaccine
candidates. Nonetheless, further development of this ani-
mal model may include the evaluation of the addition of
sand fly saliva and/or infection by sand fly bites, which
have been shown to dramatically alter host immune re-
sponse to Leishmania infection in mice [52], even though
its effects in dogs have been less straightforward [41,42].
Analysis of the immune response of L. (L.) mexicana
infected dogs indicated an increase in anti-parasite IgG
and anti-NH36 IgG levels eight weeks post-infection,
which seems much faster than that observed during in-
fection with L. (L.) chagasi/infantum in which case anti-
body levels took more than a year to increase [42,50].
However, IgG levels appeared to rise faster when intra-
dermal infection was used [53]. Nonetheless, similar to
the visceral form of the disease, for which higher IgG
levels are associated with symptomatic disease [21], we
found that a stronger humoral response was associated
with larger lesion size. Interestingly, the analysis of IgG
isotypes revealed a gradual shift from a predominant
IgG2 to a predominant IgG1 isotype over the course of
infection, suggesting an initial Th1 type immune response
at the beginning on the infection, followed by progression
to a Th2 type response at later stages. This change in im-
mune profile would explain the initial control of the lesion
leading to its healing, as well as the failure of the immune
system to achieve parasite elimination, allowing the detec-
tion of Leishmania parasite DNA in the healed lesion andlymph nodes. It is also in agreement with the pathogenic
role reported for IgG1 with L. (L.) mexicana infection in
murine models [54]. However, cytokine measurements
showed a significant IFNγ production in plasma, liver and
spleen, while IL-10 was only detected in the liver. A rather
mixed Th1/Th2 response is thus more likely to be oc-
curring, as reported in canine visceral leishmaniasis, for
which a clear immune polarization has been difficult to
observe [43,55-62]. Nonetheless, a Th1 immune response
characterized by predominant IgG2 antibodies and higher
IFNγ production seem rather associated with parasite
control, as evidenced by a significant association with
a reduced splenomegaly, and a tendency to lead to a
decreased lesion size and duration. This is in agreement
with established mouse models [63], as well as observa-
tions on canine visceral leishmaniasis. The analysis of ad-
ditional cytokines and tissues, such as draining lymph
nodes, should help further characterize the immune re-
sponse in this animal model.
Conclusions
We present here the first model of canine cutaneous
leishmaniasis caused by L. (L.) mexicana. This reprodu-
cible model presented typical ulcerated skin lesions in all
animals, with characteristics very similar to those ob-
served in naturally infected animals. Parasitological ana-
lysis clearly showed the long-term persistence of parasite
both in healed skin lesions and the lymph nodes. Also, in-
fection was associated with a mixed Th1/Th2 response, al-
though a Th1 profile seemed to be associated with better
parasite control. This model will be very useful to further
clarify the role of dogs as reservoirs and in L. (L.) mexicana
transmission cycles. Further studies should also provide
new insights on the immunopathogenesis of canine cuta-
neous leishmaniasis. Finally, this model will be very useful
for the evaluation of novel vaccine and drug candidates.
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